These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35917927)

  • 1. Hypomethylated gene RAC3 induces cell proliferation and invasion by increasing FASN expression in endometrial cancer.
    Meijuan C; Fang L; Min F; Qian W
    Int J Biochem Cell Biol; 2022 Sep; 150():106274. PubMed ID: 35917927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis identifies RAC3 as an immune-related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer.
    Huang P; Qian Y; Xia Y; Wang S; Xu C; Zhu X; Gao Q
    J Cell Mol Med; 2023 Aug; 27(16):2385-2397. PubMed ID: 37386813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF1 Activates RAC3 to Mediate Fatty Acid Synthesis and Enhance Cisplatin Resistance in Bladder Cancer Cells.
    Song L; Xu Q; Chen R; Sun W; Zhan J
    Am J Mens Health; 2024; 18(5):15579883241273305. PubMed ID: 39376007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 5. Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.
    Li H; Ma H; Ma J; Qin F; Fan S; Kong S; Zhao S; Ma J
    J Cell Mol Med; 2024 Jun; 28(11):e18473. PubMed ID: 38847477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression.
    He Y; Xu S; Qi Y; Tian J; Xu F
    J Ovarian Res; 2021 Nov; 14(1):163. PubMed ID: 34789312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
    Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
    Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAC3 is a pro-migratory co-activator of ERα.
    Walker MP; Zhang M; Le TP; Wu P; Lainé M; Greene GL
    Oncogene; 2011 Apr; 30(17):1984-94. PubMed ID: 21217774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments.
    Meijuan C; Meng X; Fang L; Qian W
    J Ovarian Res; 2023 Jan; 16(1):16. PubMed ID: 36653850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer.
    Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J
    DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer.
    Chen J; Yang P; Li S; Feng Y
    J Immunol Res; 2023; 2023():5437526. PubMed ID: 37159818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
    Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
    Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
    Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
    Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.
    Gest C; Joimel U; Huang L; Pritchard LL; Petit A; Dulong C; Buquet C; Hu CQ; Mirshahi P; Laurent M; Fauvel-Lafève F; Cazin L; Vannier JP; Lu H; Soria J; Li H; Varin R; Soria C
    BMC Cancer; 2013 Feb; 13():63. PubMed ID: 23388133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
    Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.